Evaluating clinical utility of comprehensive genomic profiling-challenges and opportunities
J Natl Cancer Inst
.
2024 Nov 8:djae237.
doi: 10.1093/jnci/djae237.
Online ahead of print.
Authors
Lisa M McShane
1
,
Lyndsay N Harris
2
Affiliations
1
Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
2
Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
PMID:
39514678
DOI:
10.1093/jnci/djae237
No abstract available
Publication types
Editorial
Comment